LCO 4655 1 of 2
General Assembly Raised Bill No. 1324
January Session, 2025
LCO No. 4655
Referred to Committee on PUBLIC HEALTH
Introduced by:
(PH)
AN ACT AUTHORIZING EMERGENCY MEDICAL SERVICES
PERSONNEL TO ADMINISTER GLUCAGON NASAL POWDER.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. (NEW) (Effective from passage) (a) As used in this section: 1
(1) "Emergency medical services personnel" means (A) any 2
emergency medical responder certified pursuant to sections 20-206ll 3
and 20-206mm of the general statutes, (B) any class of emergency 4
medical technician certified pursuant to sections 20-206ll and 20-206mm 5
of the general statutes, including, but not limited to, any advanced 6
emergency medical technician, and (C) any paramedic licensed 7
pursuant to sections 20-206ll and 20-206mm of the general statutes; and 8
(2) "Glucagon nasal powder" means a class of medications (A) 9
referred to as glycogenolytic agents that cause the liver to reduce stored 10
sugar to the blood and are intended for the treatment of severe 11
hypoglycemia in persons with diabetes who are treated with insulin, 12
and (B) administered intranasally. 13
(b) Any emergency medical services personnel who has been trained, 14 Raised Bill No. 1324
LCO 4655 2 of 2
in accordance with national standards recognized by the Commissioner 15
of Public Health, in the administration of glucagon nasal powder may 16
administer glucagon nasal powder when the use of glucagon is deemed 17
necessary by the emergency medical services personnel for the 18
treatment of a patient. All emergency medical services personnel shall 19
receive such training from an organization designated by the 20
commissioner. 21
(c) All licensed or certified ambulances may be equipped with 22
glucagon nasal powder to be administered as described in subsection 23
(b) of this section. 24
This act shall take effect as follows and shall amend the following
sections:
Section 1 from passage New section
PH Joint Favorable